Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
0
|
pubmed:dateCreated |
1974-9-5
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0071-8041
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
23
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
239-41
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:4601078-Blindness,
pubmed-meshheading:4601078-Blood Platelets,
pubmed-meshheading:4601078-Clinical Trials as Topic,
pubmed-meshheading:4601078-Humans,
pubmed-meshheading:4601078-Ischemic Attack, Transient,
pubmed-meshheading:4601078-Placebos,
pubmed-meshheading:4601078-Sulfinpyrazone
|
pubmed:year |
1972
|
pubmed:articleTitle |
Effect of drugs that suppress platelet surface interaction on incidence of amaurosis fugax and transient cerebral ishcemia.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial
|